NAFLD and NASH: etiology, targets and emerging therapies
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) pose a
significant threat to human health and cause a tremendous socioeconomic burden …
significant threat to human health and cause a tremendous socioeconomic burden …
Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle …
Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-
alcoholic fatty liver disease (NAFLD), is the most common liver disorder worldwide, with an …
alcoholic fatty liver disease (NAFLD), is the most common liver disorder worldwide, with an …
Targeting Liver Epsins Ameliorates Dyslipidemia in Atherosclerosis
Rationale: Low density cholesterol receptor (LDLR) in the liver is critical for the clearance of
low-density lipoprotein cholesterol (LDL-C) in the blood. In atherogenic conditions …
low-density lipoprotein cholesterol (LDL-C) in the blood. In atherogenic conditions …
The Influence of Diet and Its Components on the Development and Prevention of Hepatocellular Carcinoma (HCC)
B Janota, B Szymanek - Cancers, 2024 - mdpi.com
Simple Summary Due to the increasing incidence of hepatocellular carcinoma, which is a
global problem, it is valuable to present the latest available literature that describes dietary …
global problem, it is valuable to present the latest available literature that describes dietary …
[HTML][HTML] Metabolic dysfunction-associated fatty liver disease is associated with the presence of coronary atherosclerotic plaques and plaque burden
X Cai, X Su, Y Zhang, S Wang, Y Pan, A Jin… - Hellenic Journal of …, 2024 - Elsevier
Background Atherosclerosis is closely related with cardiovascular disease risk. The present
study aims to evaluate the association between metabolic dysfunction-associated fatty liver …
study aims to evaluate the association between metabolic dysfunction-associated fatty liver …